Compare TTK HEALTHCARE with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE STERLING BIOTECH TTK HEALTHCARE/
STERLING BIOTECH
 
P/E (TTM) x 25.4 -0.4 - View Chart
P/BV x 1.7 0.0 12,225.5% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 TTK HEALTHCARE   STERLING BIOTECH
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
STERLING BIOTECH
Dec-13
TTK HEALTHCARE/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,21511 11,571.4%   
Low Rs6103 17,944.1%   
Sales per share (Unadj.) Rs444.426.8 1,657.6%  
Earnings per share (Unadj.) Rs17.2-15.0 -115.3%  
Cash flow per share (Unadj.) Rs27.6-5.5 -505.8%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs177.954.9 324.2%  
Shares outstanding (eoy) m14.13267.87 5.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.10.3 792.1%   
Avg P/E ratio x52.9-0.5 -11,386.7%  
P/CF ratio (eoy) x33.0-1.3 -2,596.1%  
Price / Book Value ratio x5.10.1 4,049.7%  
Dividend payout %29.00-   
Avg Mkt Cap Rs m12,8941,862 692.6%   
No. of employees `0002.31.4 170.8%   
Total wages/salary Rs m1,307547 239.0%   
Avg. sales/employee Rs Th2,715.75,303.3 51.2%   
Avg. wages/employee Rs Th565.3403.8 140.0%   
Avg. net profit/employee Rs Th105.4-2,959.0 -3.6%   
INCOME DATA
Net Sales Rs m6,2797,181 87.4%  
Other income Rs m7843 181.9%   
Total revenues Rs m6,3567,223 88.0%   
Gross profit Rs m496947 52.3%  
Depreciation Rs m1472,543 5.8%   
Interest Rs m344,377 0.8%   
Profit before tax Rs m393-5,931 -6.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m149-1,924 -7.7%   
Profit after tax Rs m244-4,007 -6.1%  
Gross profit margin %7.913.2 59.9%  
Effective tax rate %37.932.4 116.9%   
Net profit margin %3.9-55.8 -7.0%  
BALANCE SHEET DATA
Current assets Rs m2,71714,335 19.0%   
Current liabilities Rs m1,57149,809 3.2%   
Net working cap to sales %18.3-494.0 -3.7%  
Current ratio x1.70.3 601.1%  
Inventory Days Days32403 8.0%  
Debtors Days Days47171 27.3%  
Net fixed assets Rs m99155,432 1.8%   
Share capital Rs m141268 52.7%   
"Free" reserves Rs m2,37313,935 17.0%   
Net worth Rs m2,51414,701 17.1%   
Long term debt Rs m39,478 0.0%   
Total assets Rs m4,15873,988 5.6%  
Interest coverage x12.6-0.4 -3,554.0%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x1.50.1 1,555.9%   
Return on assets %6.70.5 1,332.4%  
Return on equity %9.7-27.3 -35.6%  
Return on capital %16.9-6.4 -263.6%  
Exports to sales %3.625.9 13.8%   
Imports to sales %0.50.2 290.1%   
Exports (fob) Rs m2251,860 12.1%   
Imports (cif) Rs m3112 253.7%   
Fx inflow Rs m2251,860 12.1%   
Fx outflow Rs m7125 285.7%   
Net fx Rs m1541,835 8.4%   
CASH FLOW
From Operations Rs m1731,719 10.1%  
From Investments Rs m97-3,148 -3.1%  
From Financial Activity Rs m-3071,426 -21.5%  
Net Cashflow Rs m-38-3 1,108.8%  

Share Holding

Indian Promoters % 65.4 33.9 192.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.0 -  
FIIs % 5.2 9.9 52.5%  
ADR/GDR % 0.0 16.9 -  
Free float % 25.8 39.3 65.6%  
Shareholders   12,723 21,482 59.2%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   PROCTER & GAMBLE HEALTH  CIPLA  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Scales 42,000 and Smallcaps Rebound: What Happens Next?(Podcast)

This week, the BSE Sensex crossed 42,000 level for the first time. While Nifty followed suit, hitting a record high of 12,377.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Jan 6, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

I Made a Killing in the Markets this Week... Here's How(Profit Hunter)

Jan 10, 2020

How we made a killing in the markets amidst geopolitical tension and war mongering.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 17, 2020 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - STRIDES PHARMA SCIENCE COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS